1. Home
  2. Analysis
  3. Elidel
  4. Vulvovaginal-dryness

Elidel and Vulvovaginal dryness - a phase IV clinical study of FDA data

Summary:

Vulvovaginal dryness is reported as a side effect among people who take Elidel (pimecrolimus), especially for people who are 30-39 old, have been taking the drug for 6 - 12 months also take Decadron, and have Vitiligo.

The phase IV clinical study analyzes which people have Vulvovaginal dryness when taking Elidel. It is created by eHealthMe based on reports of 5,143 people who have side effects when taking Elidel from the FDA, and is updated regularly.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.

What is Vulvovaginal dryness?

Vulvovaginal dryness is found to be associated with 442 drugs and 516 conditions by eHealthMe. Check the latest studies of Vulvovaginal dryness.

On Jul, 16, 2026

5,143 people reported to have side effects when taking Elidel.
Among them, 14 people (0.27%) have Vulvovaginal dryness.

Could Elidel cause Vulvovaginal dryness?

Among these 14 people:

How long have people been on Elidel when they have Vulvovaginal dryness? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the age of people who have Vulvovaginal dryness when taking Elidel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 71.43 %
  • 40-49: 28.57 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Elidel? *

  1. Zofran: 10 people, 71.43%
  2. Neulasta: 10 people, 71.43%
  3. Actonel: 10 people, 71.43%
  4. Adriamycin Pfs: 10 people, 71.43%
  5. Aloxi: 10 people, 71.43%
  6. Aranesp: 10 people, 71.43%
  7. Ativan: 10 people, 71.43%
  8. Cyclophosphamide: 10 people, 71.43%
  9. Cytoxan: 10 people, 71.43%
  10. Decadron: 10 people, 71.43%

What are other side effects people have besides Vulvovaginal dryness? *

  1. Conjunctivitis (pink eye): 13 people, 92.86%
  2. Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 85.71%
  3. Breast Lump (localized swelling that feels different from the surrounding breast tissue): 12 people, 85.71%
  4. Amenorrhea (absence of a menstrual period in a woman of reproductive age): 11 people, 78.57%
  5. Irritability: 10 people, 71.43%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 10 people, 71.43%
  7. Neck Pain: 10 people, 71.43%
  8. Mood Swings (an extreme or rapid change in mood): 10 people, 71.43%
  9. Menopause (end of monthly cycles in women): 10 people, 71.43%
  10. Breast Cancer Female: 10 people, 71.43%

What are the existing conditions these people have? *

  1. Vitiligo (pigment is lost from areas of the skin): 10 people, 71.43%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and have Vulvovaginal dryness?

- Check whether Vulvovaginal dryness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elidel:

Vulvovaginal dryness treatments and more:

How severe was Vulvovaginal dryness and when was it recovered:

Expand to all the drugs that have ingredients of pimecrolimus:

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vulvovaginal dryness:

Browse all the conditions that are associated with Vulvovaginal dryness:

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.